Evidence map›Paper›PMID 39954026›Full record

ArticleArchives of toxicology2025

Unanticipated differences in the rat plasma metabolome of genistein and daidzein.

Gina Montoya, Bennard van Ravenzwaay, Walburga Seefelder, Volker Haake, Hennicke Kamp

Abstract read
In one paragraph

Article in Archives of toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Gina MontoyaSociété Des Produits Nestlé S.A, Lausanne, Switzerland.
Bennard van RavenzwaayEnvironmental Sciences Consulting, Altrip, Germany. demou@outlook.de.ORCID 0000-0002-4264-9217
Walburga SeefelderSociété Des Produits Nestlé S.A, Lausanne, Switzerland.
Volker HaakeBASF Metabolome Solutions GmbH, Berlin, Germany.
Hennicke KampBASF Metabolome Solutions GmbH, Berlin, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genistein (GEN) and daidzein (DAI) are soy isoflavones known to bind to estrogen receptors. Overall health effects of GEN and DAI in humans exhibit a dual nature, presenting both health benefits and concerns related to their interaction with the estrogen receptor. The metabolomes of these isoflavones were determined in 28-day oral studies in male and female Wistar rats to elucidate (1) metabolites changes, (2) compare their metabolomes with other compounds and (3) identify toxicological modes of action (MoA). Dose levels for GEN were 1000 and 300 mg/kg bw by gavage and 1000 and 300 ppm (via diet). DAI gavage dose levels were 1000 and 100 mg/kg bw. Results were evaluated using the MetaMap

Indexed as

GenisteinIsoflavonesMetabolomePhytoestrogensAnimalsDose-Response Relationship, DrugFemaleMaleRatsRats, WistardaidzeinGenisteinIsoflavonesPhytoestrogensDaidzeinEstrogensGenisteinMetabolomics

Identifiers

PMID39954026
PMCPMC11968494

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.